Evidence map›Paper›PMID 38662704›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

An Ensemble Framework for Projecting the Impact of Lymphatic Filariasis Interventions Across Sub-Saharan Africa at a Fine Spatial Scale.

Panayiota Touloupou, Claudio Fronterre, Jorge Cano, Joaquin M Prada, Morgan Smith, Periklis Kontoroupis, Paul Brown, Rocio Caja Rivera, Sake J de Vlas, Sharmini Gunawardena and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. New Tools and Nuanced Interventions to Accelerate Achievement of the 2030 Roadmap for Neglected Tropical Diseases.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 16 institutions in 9 countries.

Panayiota TouloupouSchool of Mathematics, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0003-4949-7591
Claudio FronterreCHICAS, Lancaster University, Lancaster, United Kingdom.
Jorge CanoExpanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN), WHO Regional Office for Africa, Brazzaville, Democratic Republic of the Congo.
Joaquin M PradaSchool of Veterinary Medicine, University of Surrey, Guildford, United Kingdom.
Morgan SmithDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Periklis KontoroupisErasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Paul BrownZeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, University of Warwick, Coventry, United Kingdom.
Rocio Caja RiveraCenter for Global Health Infectious Disease Research, University of South Florida, Tampa, USA.
Sake J de VlasErasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Sharmini GunawardenaDepartment of Parasitology, University of Colombo, Colombo, Sri Lanka.
Michael A IrvineData and Analytic Services, British Columbia Centre for Disease Control, Vancouver, Canada.
Sammy M NjengaEastern and Southern Africa Centre of International Parasite Control, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Lisa ReimerDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Fikre SeifeDisease Prevention and Control Directorate, Federal Ministry of Health, Addis Ababa, Ethiopia.
Swarnali SharmaDepartment of Mathematics, Vijaygarh Jyotish Ray College, Kolkata, India.
Edwin MichaelCenter for Global Health Infectious Disease Research, University of South Florida, Tampa, USA.
Wilma A StolkErasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Rachel PulanFaculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Simon E F SpencerZeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, University of Warwick, Coventry, United Kingdom.
T Déirdre HollingsworthBig Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom.
Erasmus MC · NLUniversity of South Florida · USUniversity of Warwick · GBBC Centre for Disease Control · CAFederal Ministry of Health · ETKenya Medical Research Institute · KELancaster University · GBLiverpool School of Tropical Medicine · GBLondon School of Hygiene & Tropical Medicine · GBRayat Shikshan Sanstha · INUniversity of Birmingham · GBUniversity of Colombo · LKUniversity of Notre Dame · USUniversity of Oxford · GBUniversity of Surrey · GBWorld Health Organization Regional Office for Africa · CG

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundLymphatic filariasis (LF) is a neglected tropical disease targeted for elimination as a public health problem by 2030. Although mass treatments have led to huge reductions in LF prevalence, some countries or regions may find it difficult to achieve elimination by 2030 owing to various factors, including local differences in transmission. Subnational projections of intervention impact are a useful tool in understanding these dynamics, but correctly characterizing their uncertainty is challenging.

methodsWe developed a computationally feasible framework for providing subnational projections for LF across 44 sub-Saharan African countries using ensemble models, guided by historical control data, to allow assessment of the role of subnational heterogeneities in global goal achievement. Projected scenarios include ongoing annual treatment from 2018 to 2030, enhanced coverage, and biannual treatment.

resultsOur projections suggest that progress is likely to continue well. However, highly endemic locations currently deploying strategies with the lower World Health Organization recommended coverage (65%) and frequency (annual) are expected to have slow decreases in prevalence. Increasing intervention frequency or coverage can accelerate progress by up to 5 or 6 years, respectively.

conclusionsWhile projections based on baseline data have limitations, our methodological advancements provide assessments of potential bottlenecks for the global goals for LF arising from subnational heterogeneities. In particular, areas with high baseline prevalence may face challenges in achieving the 2030 goals, extending the "tail" of interventions. Enhancing intervention frequency and/or coverage will accelerate progress. Our approach facilitates preimplementation assessments of the impact of local interventions and is applicable to other regions and neglected tropical diseases.

Indexed as

Elephantiasis, FilarialAfrica South of the SaharaDisease EradicationFilaricidesHumansNeglected DiseasesPrevalenceFilaricidesensemble modelsfine-scale spatial projectionsintervention impactlinking maps with modelslymphatic filariasis

Identifiers

PMID38662704
PMCPMC11045016
OpenAlexW4395467637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.